FDA Orange Book · active-ingredient family
Phenobarbital sodium
Phenobarbital sodium is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:SEZABY · NDA 215910
1
Brand (NDA)
0
Generics (ANDA)
2
Listed patents
1
Exclusivity periods
Brand (NDA) products · powder
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| SEZABYRLD | SUN PHARM INDS INC | NDA 215910 | — | Nov 17, 2022 |
Marketing exclusivity (1)
- ODE-414Orphan-drug exclusivity (7 years)
Nov 17, 2029
in 3 yr 6 mo
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 11857683 | Apr 07, 2042 | in 16 yr | ProductU-3779 |
| 12636254 | Apr 07, 2042 | in 16 yr | ProductU-3779 |
Phenobarbital sodium — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

